{"id":9512,"date":"2020-01-13T06:58:33","date_gmt":"2020-01-13T11:58:33","guid":{"rendered":"https:\/\/blogs.nejm.org\/hiv-id-observations\/?p=9512"},"modified":"2020-01-13T07:15:04","modified_gmt":"2020-01-13T12:15:04","slug":"diagnostic-tests-for-syphilis-continue-to-perplex-even-the-experts-an-unanswerable-question-in-infectious-diseases","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/diagnostic-tests-for-syphilis-continue-to-perplex-even-the-experts-an-unanswerable-question-in-infectious-diseases\/2020\/01\/13\/","title":{"rendered":"Diagnostic Tests for Syphilis Continue to Perplex Even the Experts: An Unanswerable Question in Infectious Diseases"},"content":{"rendered":"<p><a href=\"https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-9513\" src=\"https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future.png\" alt=\"\" width=\"170\" height=\"268\" srcset=\"https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future.png 976w, https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future-191x300.png 191w, https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future-768x1209.png 768w, https:\/\/blogs.nejm.org\/hiv-id-observations\/wp-content\/uploads\/sites\/2\/2020\/01\/Syphilis_false_shame_and_fear_may_destroy_your_future-651x1024.png 651w\" sizes=\"auto, (max-width: 170px) 100vw, 170px\" \/><\/a>Here&#8217;s a tricky clinical scenario:<\/p>\n<ol>\n<li>An elderly person with cognitive decline or some other non-specific neurologic symptom sees a clinician.<\/li>\n<li>Clinician sends a syphilis screen with a <em>T. pallidum<\/em> enzyme immunoassay (TP-EIA), which returns <em>positive.<\/em><\/li>\n<li>Lab runs a confirmatory test &#8212; a <em>T. pallidum<\/em> particle agglutination test (TP-PA), or similar, which also returns <em>positive.<\/em><\/li>\n<li>The lab then runs a rapid plasma reagin (RPR) test, which returns <em>negative<\/em>.<\/li>\n<li>There is no known prior clinical or lab history of syphilis exposure, diagnosis, or treatment.<\/li>\n<\/ol>\n<p>Now what are we supposed to do?<\/p>\n<p>I bring this up because Dr. Thomas Fekete raised just this issue on the IDSA&#8217;s ID Exchange message board, generating a spirited discussion.<\/p>\n<p>(I&#8217;m citing this discussion and quoting with his permission.)<\/p>\n<p>And every card-carrying ID doctor has been asked what to do in just this setting numerous times since labs started using TP-EIA &#8212; and not RPR &#8212; for syphilis screening a bit over a decade ago. In one study, this pattern (two positive treponemal tests and a negative RPR) <a href=\"https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5732a2.htm\" target=\"_blank\" rel=\"noopener noreferrer\">occurred in approximately 3% of individuals undergoing testing.<\/a><\/p>\n<p>Here&#8217;s why the next step is so controversial:\u00a0 This <em>exact<\/em> pattern describes three separate clinical scenarios, each of them requiring very different next steps. Here are the potential interpretations:<\/p>\n<ol>\n<li><strong>The result is consistent with, but not diagnostic of, neurosyphilis.<\/strong> <em>Recommendation:<\/em> Perform a CSF exam to rule out neurosyphilis. This is hardly a trivial undertaking, especially in the elderly. Further complicating this next step is that the CSF exam is notoriously poor at either ruling in or ruling out neurosyphilis. Plenty of false-positives and false-negatives.<\/li>\n<li><strong>The result suggests late-latent syphilis with an RPR that has reverted spontaneously to negative.<\/strong> <em>Recommendation:<\/em>\u00a0 Treat with benzathine penicillin 2.4 million units by intramuscular injection, weekly for 3 doses. In this interpretation, clinicians must consider the likelihood of clinical neurosyphilis to be sufficiently low that this result is unrelated to the neurologic symptoms &#8212; which begs the question, why was the test ordered in the first place?<\/li>\n<li><strong>The result demonstrates prior treated syphilis, with an adequate serologic response. <\/strong><em>Recommendation:<\/em>\u00a0 No treatment or further testing necessary. Lots of antibiotics have activity against <em>T. pallidum,<\/em> so antibiotics administered for other indications over the years have inadvertently provided sufficient treatment.<\/li>\n<\/ol>\n<p>Let&#8217;s add to the quandary by quoting Dr. Fekete on two key points:<\/p>\n<blockquote><p>I cannot find modern information about the incidence of true tertiary or neurosyphilis in elderly patients with this [testing] profile &#8230; These patients would not have come to our attention in the old system for syphilis screening.<\/p><\/blockquote>\n<p>Where are the prospective clinical series outlining either actual clinical neurosyphilis &#8212; or even CSF abnormalities &#8212; in those who have this serologic profile?<\/p>\n<p>Plus, in the pre-TP-EIA era, when we used RPR for screening, neurosyphilis would have been considered &#8220;ruled out&#8221; unless there was a <em>strong<\/em> prior probability of this disease (which there hardly ever is).<\/p>\n<p>Sometimes ignorance is bliss!<\/p>\n<p>Want a further wrinkle? Some believe that the recommended treatment for latent syphilis &#8212; benzathine penicillin, with its long half-life but low CSF concentrations &#8212; adequately treats neurosyphilis as well. The thought here is that <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJM199412013312210\" target=\"_blank\" rel=\"noopener noreferrer\">the immune system plays a role in clearing the infection<\/a>, so no need for high CNS concentrations of penicillin &#8212; except perhaps in people with immunosuppression, as is seen in untreated HIV.<\/p>\n<p>The data supporting this view (like many other aspects of clinical syphilis) are largely uncontrolled and somewhat dated &#8212; but strongly endorsed and frequently cited by advocates nonetheless.<\/p>\n<p>But this position is vociferously challenged by others &#8212; again with largely anecdotal and outdated data. This group, now in the majority, inform the current CDC guidelines for <a href=\"https:\/\/www.cdc.gov\/std\/tg2015\/syphilis.htm\" target=\"_blank\" rel=\"noopener noreferrer\">treatment of neurosyphilis<\/a>, which recommend high-dose intravenous penicillin G for 10-14 days &#8212; a burdensome treatment not easily (or cheaply!) administered to the\u00a0 elderly, especially those with cognitive impairment.<\/p>\n<p>It&#8217;s not as if this neurosyphilis quagmire were a new problem; indeed, the diagnosis of neurosyphilis has been fraught for decades. Often the leading strategy adopted by a hospital or a practice is the one endorsed the most passionately (or most loudly, in case conference) by the local expert or experts.<\/p>\n<p>All this controversy makes this case scenario a classic <em>Unanswerable Question in Infectious Diseases.<\/em> And perfect for a poll!<\/p>\n<p>So have it at &#8212; and educate us by using the comments section to justify your vote.<\/p>\n<p><em>A 78-year-old man with no known prior history of syphilis or other sexually transmitted infections is evaluated for mild cognitive decline. As part of the work-up, he has the following blood test results:\u00a0 TP-EIA positive, TP-PA positive, RPR negative.<\/em><\/p>\n<div id=\"polls-58\" class=\"wp-polls\">\n\t<form id=\"polls_form_58\" class=\"wp-polls-form\" action=\"\/index.php\" method=\"post\">\n\t\t<p style=\"display: none;\"><input type=\"hidden\" id=\"poll_58_nonce\" name=\"wp-polls-nonce\" value=\"0b0f6d37d7\" \/><\/p>\n\t\t<p style=\"display: none;\"><input type=\"hidden\" name=\"poll_id\" value=\"58\" \/><\/p>\n\t\t<p style=\"text-align: center;\"><strong>What would you recommend next?<\/strong><\/p><div id=\"polls-58-ans\" class=\"wp-polls-ans\"><ul class=\"wp-polls-ul\">\n\t\t<li><input type=\"radio\" id=\"poll-answer-190\" name=\"poll_58\" value=\"190\" \/> <label for=\"poll-answer-190\">No further tests or treatment.<\/label><\/li>\n\t\t<li><input type=\"radio\" id=\"poll-answer-191\" name=\"poll_58\" value=\"191\" \/> <label for=\"poll-answer-191\">Treatment for late-latent syphilis with benzathine penicillin.<\/label><\/li>\n\t\t<li><input type=\"radio\" id=\"poll-answer-192\" name=\"poll_58\" value=\"192\" \/> <label for=\"poll-answer-192\">CSF examination to rule-out neurosyphilis.<\/label><\/li>\n\t\t<li><input type=\"radio\" id=\"poll-answer-193\" name=\"poll_58\" value=\"193\" \/> <label for=\"poll-answer-193\">Empiric treatment of neurosyphilis without CSF examination<\/label><\/li>\n\t\t<\/ul><p style=\"text-align: center;\"><input type=\"button\" name=\"vote\" value=\"   Vote   \" class=\"Buttons\" onclick=\"poll_vote(58);\" \/><\/p><p style=\"text-align: center;\"><a href=\"#ViewPollResults\" onclick=\"poll_result(58); return false;\" title=\"View Results Of This Poll\">View Results<\/a><\/p><\/div>\n\t<\/form>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Here&#8217;s a tricky clinical scenario: An elderly person with cognitive decline or some other non-specific neurologic symptom sees a clinician. Clinician sends a syphilis screen with a T. pallidum enzyme immunoassay (TP-EIA), which returns positive. Lab runs a confirmatory test &#8212; a T. pallidum particle agglutination test (TP-PA), or similar, which also returns positive. The [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,8],"tags":[645,890,955],"class_list":["post-9512","post","type-post","status-publish","format-standard","hentry","category-health-care","category-patient-care","tag-neurosyphilis","tag-syphilis","tag-unanswerable-questions-in-infectious-diseases"],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/posts\/9512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/comments?post=9512"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/posts\/9512\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/media?parent=9512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/categories?post=9512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/hiv-id-observations\/index.php\/wp-json\/wp\/v2\/tags?post=9512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}